How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review

Despite the increasing economic assessment of biomarker-guided therapies, no clear agreement exists whether existing methods are sufficient or whether different methods might produce different cost-effectivene...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Tags: Research Source Type: research